TITLE

Generex wins approval for impaired glucose tolerance study

PUB. DATE
September 2008
SOURCE
PharmaWatch: Biotechnology;Sep2008, Vol. 7 Issue 9, p13
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article reports that the ethics committee of the University Campus Bio-Medico of Rome has approved Generex Biotechnology Corp. to conduct a trial for its oral insulin spray Generex Oral-lyn in Italy. The trial aims to determine whether Generex Oral-lyn reduces the glucose levels of patients with glucose tolerance. It also assesses the patient's satisfaction to treat pre-diabetes with a non-invasive insulin product.
ACCESSION #
34382703

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics